/GALNF

GALNF Stock - Galenica AG

Q: What is the analyst price target for GALNF?

Analyst price target information is not currently available for GALNF.

Q: What is GALNF's market cap?

Market capitalization information is not currently available for GALNF.

Healthcare|Medical - Distribution|OTC

$116.19+10.66%

+$11.19 (+10.66%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

BUY

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $127.81

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GALNF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.33

52W High$116.19

52W Low$75.25

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$3.92B	$3.75B	$4.01B	$3.83B	$3.48B
Gross Profit	$1.09B	$451.33M	$374.13M	$350.55M	$349.41M
Gross Margin	27.7%	12.0%	9.3%	9.1%	10.0%
Operating Income	$204.35M	$191.28M	$192.98M	$186.33M	$202.25M
Net Income	$182.95M	$173.60M	$165.13M	$167.68M	$172.25M
Net Margin	4.7%	4.6%	4.1%	4.4%	4.9%
EPS	$3.67	$5.72	$3.32	$3.38	$3.48

Company Overview

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Visit Website

Earnings History & Surprises

GALNF

Beat Rate

89%

Last 9 quarters

Avg Surprise

+26.2%

EPS vs Estimate

Beats / Misses

8/1

Last 12 quarters

Latest EPS

$2.30

Q1 2025

EPS Surprise History

Q3 21

+6.8%

$1.73vs$1.62

Q1 22

+4.9%

$1.94vs$1.85

Q3 22

+3.6%

$1.74vs$1.68

Q1 23

+1.7%

$1.78vs$1.75

Q2 23

+140.2%

$4.18vs$1.74

Q2 24

+16.8%

$2.30vs$1.97

Q3 24

-6.4%

$1.76vs$1.88

Q1 25

+14.4%

$2.30vs$2.01

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Mar 9, 2026	—	—	—	—
Q1 2025	Mar 11, 2025	$2.01	$2.30	+14.4%	✓ BEAT
Q3 2024	Aug 6, 2024	$1.88	$1.76	-6.4%	✗ MISS
Q2 2024	Apr 10, 2024	$1.97	$2.30	+16.8%	✓ BEAT
Q2 2023	Jun 30, 2023	$1.74	$4.18	+140.2%	✓ BEAT
Q1 2023	Mar 7, 2023	$1.75	$1.78	+1.7%	✓ BEAT
Q3 2022	Aug 9, 2022	$1.68	$1.74	+3.6%	✓ BEAT
Q1 2022	Mar 8, 2022	$1.85	$1.94	+4.9%	✓ BEAT
Q3 2021	Aug 3, 2021	$1.62	$1.73	+6.8%	✓ BEAT
Q1 2021	Mar 9, 2021	$1.57	$2.42	+54.1%	✓ BEAT
Q3 2020	Aug 4, 2020	—	$1.42	—	—
Q1 2020	Mar 10, 2020	—	$1.24	—	—
Q3 2019	Aug 6, 2019	—	$1.34	—	—
Q1 2019	Mar 12, 2019	—	$1.89	—	—
Q3 2018	Aug 8, 2018	—	$1.16	—	—
Q1 2018	Mar 13, 2018	—	$1.28	—	—
Q3 2017	Aug 8, 2017	—	$1.21	—	—
Q2 2017	Apr 7, 2017	—	$0.90	—	—
Q2 2016	Jun 30, 2016	—	$0.77	—	—
Q4 2015	Dec 31, 2015	—	$0.81	—	—